Lung cancer is caused by genetic damage to the DNA of lung cells, most often from cigarette smoking, which causes 80% to 90% of cases. The remainder come from exposure to hazardous substances like asbestos and radon gas, or from genetic mutations that arise by chance.
How common and deadly is lung cancer worldwide?
Lung cancer is the most diagnosed and deadliest cancer worldwide. In 2020 there were 2.2 million new cases and 1.8 million deaths, representing 18% of all cancer deaths.
What is the difference between small-cell and non-small-cell lung cancer?
Small-cell lung cancer makes up around 15% of cases and its cells appear small with ill-defined boundaries. Non-small-cell lung cancer makes up the remaining 85% and includes adenocarcinomas, squamous-cell carcinomas, and large-cell carcinomas, which progress and respond to treatment differently.
What is the survival rate for lung cancer?
Around 19% of people diagnosed with lung cancer survive five years from diagnosis. Survival is much higher at the earliest stage, IA1, at 92% over five years, and drops to 0% at the most advanced stage, IVB. Five-year survival is higher in women, at 22%, than in men, at 16%.
How is lung cancer diagnosed?
A definitive diagnosis of lung cancer requires a biopsy of the suspected tissue examined under a microscope by a pathologist for cancer cells. Imaging tests such as a chest X-ray, CT, PET, and MRI are used to find tumors and assess how far the cancer has spread.
When was the link between smoking and lung cancer officially established?
In 1962 the United Kingdom's Royal College of Physicians concluded that cigarette smoking causes lung cancer. The United States Surgeon General's advisory committee report, published in January 1964, found that cigarette smoking far outweighs all other factors in causing lung cancer.
Who should be screened for lung cancer?
The United States Preventive Services Task Force recommends yearly low-dose CT screening for people between 55 and 80 with a smoking history of at least 30 pack-years. Regular low-dose CT scans in high-risk people reduce total lung cancer deaths by as much as 20%.